AAV-Mediated Calpain 3 Gene Transfer (Genethon)

N/A

Report date: 2023/10/26 16:01:55

Base Information

Drug NameAAV-Mediated Calpain 3 Gene Transfer (Genethon)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCalpain-3 stimulants
TargetsCalpain-3
Therapy Area/IndicationsMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenethonSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenethon
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophies, Limb-Girdle

Other Information

ATC CodeN/A
Related LinksN/A